Brought to you by 
Japan Tobacco sells Gilead's HIV drugs in Japan; terminated
21 Dec 2020
Executive Summary
Diversified Japanese company Japan Tobacco (JT) will sell Gilead Sciences' (anti-infectives) HIV therapeutics Viread (tenofovir disoproxil fumarate) and Emtriva (emtricitabine) in Japan.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Alliance
- Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Japan Tobacco sells Gilead's HIV drugs in Japan; terminated
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice